Floatz logo

.ALPHA.-1 PROTEASE INHIBITOR

Pancreatitis, Chronic; Diabetes; Transplant

University of Minnesotaprotein_peptidePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pancreatitis, Chronic; Diabetes; Transplant cohort.

Asset / SponsorPhaseRating
1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER
University of Minnesota
Phase 4BB

Same molecule, other indications

.ALPHA.-1 PROTEASE INHIBITOR is also rated in:

alpha 1-antitrypsin deficiencyDormant
A
Indicative ·
81 / 100
View asset →
Chronic Obstructive Pulmonary DiseaseDormant
BBB
Indicative ·
72 / 100
View asset →
alpha 1-antitrypsin deficiencyDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →